poisar

Stock

Decoy Therapeutics Inc. DCOY

$3.59+1.70%

Overview

DCOY market data

Price History

DCOY price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$5.79
Diluted earnings per share over the trailing twelve months.
Beta
0.62
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-179.1%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$3.51 – $106.20
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $2.4M · P/B 0.71 · P/S 0.50.

Company News

10 captured
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-AssociatedBenzinga · Aug 7, 2026, 3:06 PM
Decoy Therapeutics Announces The Expansion Of Its Intellectual Property Portfolio, Which Now Comprises Seven Patent FamiliesBenzinga · Aug 3, 2026, 1:05 PM
Decoy Therapeutics shares are trading lower. The company announced that one of its D-MAV candidates demonstrates in vitro activity against wild-type Ebola Zaire virus in testing at the Texas Biomedical Research Institute.Benzinga · Jul 27, 2026, 5:58 PM
Decoy Therapeutics Announces That One Of Its D-MAV Candidates Demonstrates In Vitro Activity Against Wild-Type Ebola Zaire VirusBenzinga · Jul 27, 2026, 1:04 PM
Decoy Therapeutics Files Prospectus For Offering 3.767M Common Shares On Behalf Of Common ShareholdersBenzinga · Jul 10, 2026, 8:35 PM
Crude Oil Gains 2%; Comcast Shares Spike HigherBenzinga · Jun 29, 2026, 4:35 PM
Decoy Stock Rises After Announcing Up to $21 Million Private Placement FinancingBenzinga · Jun 29, 2026, 2:00 PM
Nasdaq Jumps More Than 1%; Comcast Shares Spike HigherBenzinga · Jun 29, 2026, 1:45 PM
Market-Moving News for June 29thBenzinga · Jun 29, 2026, 11:15 AM
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving PremarketBenzinga · Jun 29, 2026, 11:05 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock